Cancer :: Treatment induced factor causes cancer progression
In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment.
In advanced cancer, anti-tumor therapies often work only partially or not at all, and tumors progress following treatment.
ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced that a first line Phase III study of ERBITUX(R) (Cetuximab) combined with platinum-based chemotherapy met the primary endpoint of increasing overall survival in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
An international team led by researchers from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has identified a genetic variant that is a major contributor to small size in dogs.
A research team at the Vanderbilt-Ingram Cancer Center, led by Carlos Arteaga, M.D., reports in the May issue of the Journal of Clinical Investigation that radiation and chemotherapy increase circulating levels of the growth factor TGF-beta, circulating cancer cells, and tumor metastases in a mouse model of metastatic breast cancer.
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.
Natural alternatives to antibiotics in stockfeed may be on the menu for sheep and cattle if new research is confirmed.
Each year an estimated 20 million children are born with low birth weight worldwide, more than 95% of them in developing countries.
The U.S. Government through the U.S. Agency for International Development (USAID) announced a three-year contract to bolster international capacity for avian and pandemic influenza response.
Skin cancer experts have expressed alarm at new Cancer Council research showing an explosion in solarium numbers across Australia, with one capital city recording a 1000 per cent increase over the past decade.
The number of people in the U.S. with macular degeneration is greater than that with all types of cancer combined. Macular degeneration can lead to blindness, something that people fear even more than premature death. This award will help further research into this condition.